[Remarkable response to cladribine in the treatment for hairy B cell lymphoproliferative disorder].
Takeshita
Taketsugu
T
National Hospital Organization Kagoshima Medical Center, Kagoshima.
Owatari
Satsuki
S
Otsuka
Maki
M
Hanada
Shuichi
S
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001402:B-Lymphocytes / Q000473:pathology*; D017338:Cladribine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008232:Lymphoproliferative Disorders / Q000188:drug therapy* / Q000473:pathology; D008875:Middle Aged; D016896:Treatment Outcome